Exact Mass: 328.2766
Exact Mass Matches: 328.2766
Found 373 metabolites which its exact mass value is equals to given mass value 328.2766,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Stanozolol
Stanozolol is only found in individuals that have used or taken this drug. Stanozolol has is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanozolol was first synthesized by Clinton et al. in 1959, as a heterocyclic anabolic androgenic steroid. The structure of Stanozolol differs from endogenous steroid hormones and most commercially available anabolic steroids. It most closely resembles methyl testosterone. Instead of the 3-ketogroup in methyltestosterone, there is a pyrazole ring fused to the androstane ring system. This slightly different structure has the disadvantage of making extraction and isolation of the molecule from matrices more difficult. Like most other anabolic steroids, Stanozolol has poor gas chromatographic behavior and is difficult to detect in urine, because of renal clearance and low urinary excretion. This is due to the rapid metabolization, leading to low concentration levels of the parent compound found in urine. Therefore, most research studies had focused on the detection of urinary metabolites. Androgens are drugs, derived from the natural male sex hormone testosterone, with high anabolic potential and minimized androgenic activity. It has been abused by several high profile professional athletes. Stanozolol binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP). Anabolic steroids stimulate protein synthesis, resulting in an acceleration of the food conversion rate and increasing muscle growth, body mass and enhanced performance. Androgens can be used as therapeutics, because they accelerate the recovery of protein deficiency and protein-wasting disorders (e.g. osteoporosis), but they are also widely abused in doping, as well in animals as in men. (PMID: 10404632, 10435307, 11175645, 11284331, 12064656, 12580506, 1448813, 14698206, 15013688, 15458725, 15631866, 15664350, 16040239, 16259046, 16288903, 1640693, 17066372, 17146762, 2306548, 2362445, 2625454, 2663904, 6539197, 9001957, 9300863, 9580049). Stanozolol was first synthesized by Clinton et al. in 1959, as a heterocyclic anabolic androgenic steroid. The structure of Stan differs from endogenous steroid hormones and most commercially available anabolic steroids. It most closely resembles methyl testosterone. Instead of the 3-ketogroup in methyltestosterone, there is a pyrazole ring fused to the androstane ring system. This slightly different structure has the disadvantage of making extraction and isolation of the molecule from matrices more difficult. Like most other anabolic steroids, Stan has poor gas chromatographic behavior and is difficult to detect in urine, because of renal clearance and low urinary excretion. This is due to the rapid metabolization, leading to low concentration levels of the parent compound found in urine. Therefore, most research studies had focused on the detection of urinary metabolites. A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
Docosahexaenoic acid
Docosahexaenoic acid (DHA) is an omega-3 essential fatty acid. Chemically, DHA is a carboxylic acid with a 22-carbon chain and six cis- double bonds with the first double bond located at the third carbon from the omega end. DHA is most often found in fish oil. It is a major fatty acid in sperm and brain phospholipids, especially in the retina. Dietary DHA can reduce the level of blood triglycerides in humans, which may reduce the risk of heart disease (Wikipedia). Docosahexaenoic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism. Extensively marketed as a dietary supplement in Japan [DFC]. Doconexent is found in many foods, some of which are mung bean, fruit preserve, northern pike, and snapper. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.
2-hydroxyphytanic acid
A methylated long-chain hyroxy fatty acid formed during alpha-oxidation of phytanic acid by liver mitochondria and peroxisomes, but it is detected in tissues only in patients with peroxisomal disorders.
Promestriene
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03C - Estrogens > G03CA - Natural and semisynthetic estrogens, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Avocadene 4-acetate
Avocadene 4-acetate is found in fruits. Avocadene 4-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 4-acetate is found in fruits.
Avocadene 1-acetate
Avocadene 1-acetate is found in fruits. Avocadene 1-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 1-acetate is found in fruits.
3-hydroxyicosanoic Acid
3-hydroxyicosanoic Acid is also known as 3-Hydroxyeicosanoate or 3-Hydroxyarachidic acid. 3-hydroxyicosanoic Acid is considered to be practically insoluble (in water) and acidic. 3-hydroxyicosanoic Acid can be synthesized from arachidic acid. 3-hydroxyicosanoic Acid can be synthesized into 3-hydroxyicosanoyl-CoA. 3-hydroxyicosanoic Acid is a fatty acid lipid molecule
Grifolin
Grifolin is found in mushrooms. Grifolin is isolated from the edible maitake mushroom (Grifola confluens Isolated from the edible maitake mushroom (Grifola confluens). Grifolin is found in mushrooms.
(Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol
(Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol is found in nuts. (Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol is a constituent of cashew nut shell oil (Anacardium occidentale). Constituent of cashew nut shell oil (Anacardium occidentale). (Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol is found in nuts.
MG(16:1(9Z)/0:0/0:0)
MG(16:1(9Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(16:1(9Z)/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(16:1(9Z)/0:0/0:0) is made up of one 9Z-hexadecenoyl(R1).
Neogrifolin
Neogrifolin is found in mushrooms. Neogrifolin is a constituent of Albatrellus ovinus Constituent of Albatrellus ovinus. Neogrifolin is found in mushrooms.
Retinol acetate
Retinol acetate is a dietary supplement, permitted in infant formula Dietary supplement, permitted in infant formulas Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities.
2(R)-hydroxyicosanoic acid
2(R)-Hydroxyicosanoic acid is along-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.
MG(0:0/16:1(9Z)/0:0)
MG(0:0/16:1(9Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(0:0/16:1(9Z)/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/16:1(9Z)/0:0) is made up of one 9Z-hexadecenoyl(R2).
Avocadene 2-acetate
Avocadene 2-acetate is found in fruits. Avocadene 2-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 2-acetate is found in fruits.
Polyoxyethylene 40 monostearate
Polyoxyethylene 40 monostearate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials It is used as a food additive .
12-hydroxyicosanoic acid
12-Hydroxyicosanoic acid is a long-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.
15-hydroxyicosanoic acid
15-Hydroxyicosanoic acid is a long-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.
N-Lauroyl Glutamine
N-lauroyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Lauroyl Lysine
N-lauroyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Lysine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Methyl 8-[3-(2-hydroxyoctyl)oxiran-2-yl]octanoate
9-cis Retinol Acetate
Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities.
(4E,7E,10Z,13E,16E,19E)-Docosa-4,7,10,13,16,19-hexaenoic acid
Promestrienum
FA 22:6
Chemical was purchased from CAY 90310 (Lot. 0458708-4); Diagnostic ions: 327.1, 283.2, 229.7,191.1, 177.2 COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials CONFIDENCE standard compound; INTERNAL_ID 296 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.
Uvarisesquiterpene C
Cervonic acid
Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.
2,4-Dimethyl-6-(3-methyl-isobuten-5-isopropyl)-phenyl-3,5-hexanedione
5-methyl-2-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]-1,4-benzenediol
(5alpha)-4,4,8,10,14-pentamethylgon-12-ene-3,17-dione|cylindrictone F
11-n-octyltetracyclo[5,4,2,0(3,13)0(10,12)]trideca-4,8-dien-6-oic acid|beilschmiedic acid E
11-n-octyltetracyclo[5,4,2,0(3,13)0(10,12)]trideca-5,8-dien-6-oic acid|beilschmiedic acid D
4-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-5-methyl-2-(3-methylbut-2-enyl)benzene-1,3-diol
20-hydroxyicosanoic acid
An omega-hydroxy fatty acid that is icosanoic acid (arachidonic acid) in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.
(+)-sempervirol acetate|Semipervirol-acetat|sempervirol acetate|Sempervirolacetat|semperviryl acetate|Semperviryl-acetat
albatrellutin|[3R-(7,11-dimethylnona-6,10-dienyl)-3,7-dimethyl-chroman-1-ol]
docosa-4,8,12,15,18,21-hexaenoic acid|Docosa-4,8,12,15,18,21-hexaensaeure|Docosahexaensaeure aus Fischoelen
DHA-[21,21,22,22,22-d5]
Chemical was purchased from CAY 10005057 (Lot. 0462571-3); Diagnostic ions: 332.2, 288.4, 234.1,196.2, 182.2
Stanozolol
A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
DHA-[d5]
NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ]; CONFIDENCE standard compound CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ]; CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
2,4-dihydroxyheptadec-16-enyl acetate [IIN-based on: CCMSLIB00000848387]
2,4-dihydroxyheptadec-16-enyl acetate [IIN-based: Match]
1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based: Match]
1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based on: CCMSLIB00000845027]
Retinyl acetate
C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents D007155 - Immunologic Factors Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities.
2-Hydroxyphytanic acid
An alpha-hydroxy fatty acid formed from phytanic acid by bacterial cytochrome P450; and also formed in human peroxisomal disorders.
(Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol
2-methyl-5-(8Z.11,14-pentadecatrienyl) resorcinol
1-[3-(tert-Butoxycarbonyl-Methyl-amino)-propyl]-piperidine-4-carboxylic acid ethyl ester
(2R)-2-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]propanal
1,9-Nonanediyl-bis(3-methylimidazolium) difluoride solution
tert-Butyl (S)-4-(dimethylamino)-1-(piperazine-1-carbonyl)butylcarbamate
Zuretinol acetate
C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents D007155 - Immunologic Factors
Polyoxyethylene stearate
D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials
5-(Pentadeca-8,11,14-trien-1-yl)resorcinol monomethyl ether
omega-Hydroxyphytanic acid
A hydroxy fatty acid obtained by hydroxylation of one of the two terminal methyl groups of phytanic acid.
(4E,7E,10Z,13E,16E,19E)-Docosa-4,7,10,13,16,19-hexaenoic acid
[3-carboxy-2-[(E)-undec-4-enoyl]oxypropyl]-trimethylazanium
(3-Carboxy-2-undec-10-enoyloxypropyl)-trimethylazanium
[3-carboxy-2-[(E)-undec-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-undec-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-undec-5-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-undec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-undec-3-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-undec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-undec-8-enoyl]oxypropyl]-trimethylazanium
[(E)-2-(carboxymethyl)-2-hydroxy-3-oxotridec-4-enyl]-trimethylazanium
acetic acid [(4bS)-4b,8,8-trimethyl-1-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl] ester
6alpha-Methylprogesterone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
N,N-dimethylsphingosine(1+)
A sphingoid base(1+) that is the conjugate acid of N,N-dimethylsphingosine, obtained by protonation of the primary amino group; major species at pH 7.3.
C20 sphingosine(1+)
A cationic sphingoid that is the conjugate acid of C20 sphingosine, obtained by protonation of the primary amino function; major species at pH 7.3.
(19R)-19-hydroxyicosanoic acid
An (omega-1)-hydroxy fatty acid that is arachidic acid acid in which the 19-pro-R hydrogen is replaced by a hydroxy group.
(1R,2S,10S,13R,14R,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol
N-[(5S)-5-(hexanoylamino)-6-hydroxyhexyl]hexanamide
6-[[[(1S)-1-(4-ethylphenyl)-2-methylpropyl]amino]methyl]-2-N,2-N-dimethyl-1,3,5-triazine-2,4-diamine
[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] acetate
[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] propanoate
(1S,2S,10S,13R,14S,17S,18R)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol
Doconexent
A docosahexaenoic acid having six cis-double bonds at positions 4, 7, 10, 13, 16 and 19. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.
(2S)-2-hydroxyphytanic acid
A 20-carbon, methyl-branched hydroxy fatty acid and intermediate in phytanic acid degradation; accumulates in patients with peroxisimal disorders.
2-[(9Z)-hexadecenoyl]glycerol
A monoacylglycerol 16:1 in which the acyl group specified at position 2 is 9Z)-hexadecenoyl.
2-hydroxyarachidic acid
A long-chain fatty acid that is arachidic (icosanoic) acid substituted at position 2 by a hydroxy group.
3-hydroxyicosanoic acid
A long-chain fatty acid that is icosanoic acid carrying a 3-hydroxy substituent.
monoacylglycerol 16:1
A monoglyceride in which the acyl group contains a total of 16 carbon atoms and 1 double bond.
2-acylglycerol 16:1
A 2-monoglyceride in which the acyl group contains 16 carbons and 1 double bond.
[(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methyl acetate
(4e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-4-en-6-one
2-(4,8-dimethylnona-3,7-dien-1-yl)-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol
(2s,4as,10as)-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-2-yl acetate
(2r)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,7-dimethyl-3,4-dihydro-1-benzopyran-6-ol
3-methoxy-2-[(1r,6r)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-5-pentylphenol
6-isopropyl-4,5-dimethoxy-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7-tetraene
(5e,8e,11e,14e,17e,20e)-docosa-5,8,11,14,17,20-hexaenoic acid
(4s,4ar,6as,11ar,11br)-4-(hydroxymethyl)-4,6a,8,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-7-ol
2-[(3r,6e,10z)-6,10-dimethylbicyclo[12.1.0]pentadeca-1,6,10,14-tetraen-3-yl]propan-2-yl acetate
2,4-dimethyl-6-(3'-m ethyl-isobuten-5'-iso-propyl)-phenyl-3,5-hexanedione
{"Ingredient_id": "HBIN004352","Ingredient_name": "2,4-dimethyl-6-(3'-m ethyl-isobuten-5'-iso-propyl)-phenyl-3,5-hexanedione","Alias": "NA","Ingredient_formula": "C22H32O2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6374","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2z-phytene-1,15,20-triol
{"Ingredient_id": "HBIN006868","Ingredient_name": "2z-phytene-1,15,20-triol","Alias": "NA","Ingredient_formula": "C20H40O3","Ingredient_Smile": "CC(CCCC(C)CCCC(C)(C)O)CCCC(=CCO)CO","Ingredient_weight": "328.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "17241","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12080816","DrugBank_id": "NA"}
3-epicaonamine
{"Ingredient_id": "HBIN008471","Ingredient_name": "3-epicaonamine","Alias": "NA","Ingredient_formula": "C22H36N2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25801","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-epiconamine
{"Ingredient_id": "HBIN008472","Ingredient_name": "3-epiconamine","Alias": "NA","Ingredient_formula": "C22H36N2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6872","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9,12-dihydroxy-15-nonadecenoic acid
{"Ingredient_id": "HBIN013990","Ingredient_name": "9,12-dihydroxy-15-nonadecenoic acid","Alias": "9,12-dihydroxy-15-nonadecenoicacid","Ingredient_formula": "C19H36O4","Ingredient_Smile": "CCCC=CCCC(CCC(CCCCCCCC(=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25887;6046","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
